AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention
AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More
Covid antibody candidate AZD7442 : AstraZeneca, US strike deal for additional doses
AstraZeneca has agreed to supply the US government with up to half a million additional doses of AZD7442, the company’s Covid-19 antibody candidate, for a ... Read More
AstraZeneca to advance AZD7442 into phase 3 Covid-19 trials
AstraZeneca said that AZD7442, which is being developed for the prevention and treatment of Covid-19, will move into two phase 3 clinical trials. AZD7442 is ... Read More